Brucella abortus RB51 lipopolysaccharide influence as an adjuvant on the therapeutic efficacy of HPV16 L1 and HPV16 E7 DNA vaccines

Brucella abortus RB51 lipopolysaccharide influence as an adjuvant on the therapeutic efficacy of HPV16 L1 and HPV16 E7 DNA vaccines

Objective(s): Human papillomavirus (HPV) is a primary contributing agent of cervical cancer. Eradication of HPV-related infections requires therapeutic strategies. We used Brucella abortus RB51 rough lipopolysaccharide (R-LPS) as an adjuvant along with two HPV16 therapeutic DNA vaccines, pcDNA3-E7 a...

Full description

Bibliographic Details
Main Authors: Masoumeh Shirmohammadi, Hoorieh Soleimanjahi, Zahra Kianmehr, Hesam Karimi, Sussan Kabudanian Ardestani
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2021-01-01
Series:Iranian Journal of Basic Medical Sciences
Subjects:
adjuvant
brucella abortus rb51
cervical cancer
dna vaccines
human papillomavirus
lipopolysaccharide
Online Access:https://ijbms.mums.ac.ir/article_17049_c655752d096af5d58706ad4efdf37fba.pdf

Internet

https://ijbms.mums.ac.ir/article_17049_c655752d096af5d58706ad4efdf37fba.pdf

Similar Items